Yahoo Web Search

Search results

1. • 

     Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 1 day ago

     Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript May 8, 2024 Amphastar...

2. • Amphastar Pharmaceuticals Reports Strong First Quarter Earnings,

     Guru Focus· 9 hours ago

     On May 8, 2024, Amphastar Pharmaceuticals Inc (AMPH, Financial) disclosed its financial results for the first quarter ended March 31, 2024, through an 8 ...

3. • Federal Circuit Review - April 2024 | JD Supra

     JD Supra· 19 hours ago

     In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals Usa, Inc., Appeal No. 22-1258, the Federal Circuit held that ...

4. • Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

     Digital Journal· 2 days ago

     Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 8, 2024 / Amphastar Pharmaceuticals, Inc& ...

5. • Q1 2024 Amneal Pharmaceuticals Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 7 days ago

     Participants Tony Dimeo; Head of IR; Amneal Pharmaceuticals Inc Chirag Patel; President, Co-CEO, Co-Founder, & Director; Amneal Pharmaceuticals ...

6. • US FTC Continues Aggressive Scrutiny of Pharmaceutical Patents Listed in the Orange Book | JD Supra

     JD Supra· 19 hours ago

     On April 30, 2024, the US Federal Trade Commission (“FTC”) announced that it had sent “warning letters” to 10 branded pharmaceutical manufacturers, alleging that the companies ...

7. • 

     How sham patents are hurting the pharma industry

     Pharmaceutical Technology via Yahoo Finance· 4 days ago

     Recent legal developments, such as the Supreme Court decision in the case of Thryv, Inc. v. Click-to-Call Technologies, L.P., in 2020 have made it easier...

8. • PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug...

     Digital Journal· 13 hours ago

     (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced receipt of an Amendment Acknowledgment Letter (“AAL”) for its ...